Athens Medical C.S.A. (ATH:IATR)
Greece
· Delayed Price · Currency is EUR 1.775
+0.020 (1.14%)
Jun 6, 2025, 5:10 PM EET
Athens Medical C.S.A. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 269.85 | 258.36 | 233.42 | 226 | 187.5 | Upgrade
|
| Revenue Growth (YoY) | 4.44% | 10.69% | 3.28% | 20.53% | -4.95% | Upgrade
|
| Cost of Revenue | 209.08 | 191.81 | 176.61 | 168.21 | 146.78 | Upgrade
|
| Gross Profit | 60.76 | 66.56 | 56.81 | 57.79 | 40.72 | Upgrade
|
| Selling, General & Admin | 48.73 | 45.5 | 40.63 | 37.26 | 32.5 | Upgrade
|
| Other Operating Expenses | -3.12 | -2 | -2.39 | -2.91 | -0.66 | Upgrade
|
| Operating Expenses | 45.81 | 43.68 | 38.54 | 35.05 | 32.92 | Upgrade
|
| Operating Income | 14.96 | 22.87 | 18.28 | 22.73 | 7.8 | Upgrade
|
| Interest Expense | -10.7 | -9.33 | -7.64 | -6.55 | -6.14 | Upgrade
|
| Interest & Investment Income | 0.32 | 0.33 | 0.12 | 0.2 | 2.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.13 | -0.13 | -0.13 | -0.13 | -0.19 | Upgrade
|
| EBT Excluding Unusual Items | 4.45 | 13.75 | 10.64 | 16.26 | 3.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.05 | -0.05 | 0.08 | -1.37 | 0.05 | Upgrade
|
| Other Unusual Items | - | - | - | 0.45 | - | Upgrade
|
| Pretax Income | 4.5 | 13.7 | 10.71 | 15.34 | 3.62 | Upgrade
|
| Income Tax Expense | 2.61 | 5.54 | 3.8 | 3.3 | 1.19 | Upgrade
|
| Earnings From Continuing Operations | 1.89 | 8.16 | 6.92 | 12.04 | 2.43 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 3.1 | 1.54 | Upgrade
|
| Net Income to Company | 1.89 | 8.16 | 6.92 | 15.14 | 3.97 | Upgrade
|
| Minority Interest in Earnings | -0.11 | -0.08 | -0.07 | -0.09 | -0.05 | Upgrade
|
| Net Income | 1.78 | 8.08 | 6.85 | 15.05 | 3.92 | Upgrade
|
| Net Income to Common | 1.78 | 8.08 | 6.85 | 15.05 | 3.92 | Upgrade
|
| Net Income Growth | -77.99% | 18.05% | -54.51% | 283.54% | -48.29% | Upgrade
|
| Shares Outstanding (Basic) | 87 | 87 | 87 | 87 | 87 | Upgrade
|
| Shares Outstanding (Diluted) | 87 | 87 | 87 | 87 | 87 | Upgrade
|
| EPS (Basic) | 0.02 | 0.09 | 0.08 | 0.17 | 0.05 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.09 | 0.08 | 0.17 | 0.05 | Upgrade
|
| EPS Growth | -77.99% | 18.05% | -54.51% | 283.54% | -48.29% | Upgrade
|
| Free Cash Flow | 19.82 | 3.78 | -15.75 | 4.47 | 33.13 | Upgrade
|
| Free Cash Flow Per Share | 0.23 | 0.04 | -0.18 | 0.05 | 0.38 | Upgrade
|
| Dividend Per Share | - | 0.020 | - | 0.070 | - | Upgrade
|
| Gross Margin | 22.52% | 25.76% | 24.34% | 25.57% | 21.72% | Upgrade
|
| Operating Margin | 5.54% | 8.85% | 7.83% | 10.06% | 4.16% | Upgrade
|
| Profit Margin | 0.66% | 3.13% | 2.93% | 6.66% | 2.09% | Upgrade
|
| Free Cash Flow Margin | 7.34% | 1.46% | -6.75% | 1.98% | 17.67% | Upgrade
|
| EBITDA | 25.78 | 32.85 | 27.64 | 31.48 | 16.29 | Upgrade
|
| EBITDA Margin | 9.55% | 12.71% | 11.84% | 13.93% | 8.69% | Upgrade
|
| D&A For EBITDA | 10.83 | 9.98 | 9.36 | 8.75 | 8.49 | Upgrade
|
| EBIT | 14.96 | 22.87 | 18.28 | 22.73 | 7.8 | Upgrade
|
| EBIT Margin | 5.54% | 8.85% | 7.83% | 10.06% | 4.16% | Upgrade
|
| Effective Tax Rate | 58.06% | 40.44% | 35.44% | 21.51% | 32.79% | Upgrade
|
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.